Non-steroidal MRAs: A new treatment pillar for chronic kidney disease in type 2 diabetes

1 Apr 2023 13:00 14:00

MR 109 ABFE

Organized by Bayer

Organized by

Time	Session

13:00 13:10	Welcome and introductions Masaomi Nangaku
13:10 13:25	MRAs in 2023: still all the same? Angela Wang
13:45 13:55	Slowing CKD progression and reducing CV events with Finerenone Roberto Pecoits-Filho
13:55 14:00	Close Masaomi Nangaku